eFFECTOR Therapeutics Ownership 2024 | Who Owns eFFECTOR Therapeutics Now?

Overview Forecast RevenueFinancials Chart

Institutional Ownership

2.94%

Insider Ownership

2.91%

Retail Ownership

94.15%

Institutional Holders

2.00

eFFECTOR Therapeutics Institutional Shareholders

Institutional Shareholders by % of Total Shares

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
PARALLEL ADVISORS, LLC	1.66%	0.00%	67,738	-	-	19,651	Jun 30, 2024
BLACKSTONE INC.	1.28%	0.00%	52,343	-	-	15,185	Jun 30, 2024

eFFECTOR Therapeutics's largest institutional shareholder is PARALLEL ADVISORS, LLC, holding 1.66% of the company's total share outstanding, currently valued at $19.65K. The top 10 institutional shareholders own together 2.94% of the company.

Institutional Shareholders by % of Total Assets

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
PARALLEL ADVISORS, LLC	1.66%	0.00%	67,738	-	-	19,651	Jun 30, 2024
BLACKSTONE INC.	1.28%	0.00%	52,343	-	-	15,185	Jun 30, 2024

The largest eFFECTOR Therapeutics shareholder by % of total assets is PARALLEL ADVISORS, LLC. The company owns 67.74K shares of eFFECTOR Therapeutics (EFTR), representing 0.00% of its total assets.

Institutional Buyers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
BLACKSTONE INC.	1.28%	0.00%	52,343	-	-	15,185	Jun 30, 2024
PARALLEL ADVISORS, LLC	1.66%	0.00%	67,738	-	-	19,651	Jun 30, 2024

As of Jun 30 2024, eFFECTOR Therapeutics's largest institutional buyer is BLACKSTONE INC.. The company purchased 0.00 stocks of EFTR, valued at $15.19K.

Institutional Sellers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
PARALLEL ADVISORS, LLC	1.66%	0.00%	67,738	-	-	19,651	Jun 30, 2024
BLACKSTONE INC.	1.28%	0.00%	52,343	-	-	15,185	Jun 30, 2024

As of Jun 30 2024, eFFECTOR Therapeutics's biggest institutional seller is PARALLEL ADVISORS, LLC. The company sold 0.00 shares of EFTR, valued at $19.65K.

Institutional New positions

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date

Institutional Sold Out

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date

eFFECTOR Therapeutics Mutual Fund Holders

Name	% Total Assets	Total Shares	Change Amount	Change %	Date
ALPS ETF Trust	0.00%	43,828	-	-	Feb 29, 2024
VANGUARD INDEX FUNDS	0.00%	829,705	-	-	Mar 31, 2024
FIDELITY CONCORD STREET TRUST	0.00%	330,677	-	-	Feb 29, 2024
VANGUARD INSTITUTIONAL INDEX FUNDS	0.00%	9,544	-	-	Mar 31, 2024
ETF Series Solutions	0.00%	5,108	-	-	Jan 31, 2024
VANGUARD INDEX FUNDS	0.00%	92,465	92,465	-	Mar 31, 2024
FIDELITY CONCORD STREET TRUST	0.00%	15,175	15,175	-	Feb 29, 2024
USAA MUTUAL FUNDS TRUST	0.00%	4,205	-	-	Jan 31, 2024
iSHARES TRUST	0.00%	50,531	-	-	Mar 31, 2024
EQ ADVISORS TRUST	0.00%	1,991	-	-	Mar 31, 2024
JOHN HANCOCK VARIABLE INSURANCE TRUST	0.00%	584	-	-	Mar 31, 2024

eFFECTOR Therapeutics's largest mutual fund holder by % of total assets is "ALPS ETF Trust", owning 43.83K shares, compromising 0.00% of its total assets.

eFFECTOR Therapeutics Institutional Ownership Trends

Institutional Holdings Trend

Date	Holdings	Change %
30 Jun, 24	2	-
31 Mar, 24	2	-92.00%
31 Dec, 23	25	-13.79%
30 Sep, 23	29	-17.14%
30 Jun, 23	35	29.63%
31 Mar, 23	27	-12.90%
31 Dec, 22	31	14.81%
30 Sep, 22	27	17.39%
30 Jun, 22	23	27.78%
31 Mar, 22	18	5.88%
31 Dec, 21	17	41.67%
30 Sep, 21	12	-

As of 30 Jun 24, 2 institutions are holding eFFECTOR Therapeutics's shares, representing an increase of 0.00% compared to the previous quarter.

Shares Outstanding Trend

Date	Shares Outstanding	Change %
30 Jun, 24	120,081	-
31 Mar, 24	120,081	-98.97%
31 Dec, 23	11,685,202	-50.21%
30 Sep, 23	23,468,478	-3.95%
30 Jun, 23	24,433,689	3.52%
31 Mar, 23	23,602,595	-2.96%
31 Dec, 22	24,322,398	1.54%
30 Sep, 22	23,953,044	-0.65%
30 Jun, 22	24,110,440	7.29%
31 Mar, 22	22,473,205	5.01%
31 Dec, 21	21,402,003	59.39%
30 Sep, 21	13,427,860	-

eFFECTOR Therapeutics (EFTR) has 120.08K shares outstanding as of 30 Jun 24, up 0.00% compared to the previous quarter.

Institutional Ownership Trend

Date	Ownership %	Change %
30 Jun, 24	2.94%	9.76%
31 Mar, 24	5.49%	958.91%
31 Dec, 23	0.76%	0.03%
30 Sep, 23	49.07%	1.45%
30 Jun, 23	58.17%	1.84%
31 Mar, 23	56.20%	1.61%
31 Dec, 22	59.06%	1.74%
30 Sep, 22	58.18%	1.69%
30 Jun, 22	58.64%	1.94%
31 Mar, 22	55.02%	1.96%
31 Dec, 21	53.00%	4.79%
30 Sep, 21	33.25%	-

As of 30 Jun 24, eFFECTOR Therapeutics is held by 2.94% institutional shareholders, representing a 9.76% growth compared to 31 Mar 24.

Institutional Increased Positions Trend

Date	Increased Positions	Change %
30 Jun, 24	-	-
31 Mar, 24	-	-100.00%
31 Dec, 23	10	-16.67%
30 Sep, 23	12	-14.29%
30 Jun, 23	14	55.56%
31 Mar, 23	9	-18.18%
31 Dec, 22	11	-
30 Sep, 22	11	-15.38%
30 Jun, 22	13	62.50%
31 Mar, 22	8	-33.33%
31 Dec, 21	12	-
30 Sep, 21	12	-

- institutional shareholders have increased their position in EFTR stock as of 30 Jun 24 compared to - in the previous quarter (a 0.00% increase).

Institutional Reduced Positions Trend

Date	Reduced Positions	Change %
30 Jun, 24	-	-100.00%
31 Mar, 24	2	-50.00%
31 Dec, 23	4	33.33%
30 Sep, 23	3	-
30 Jun, 23	3	-50.00%
31 Mar, 23	6	100.00%
31 Dec, 22	3	50.00%
30 Sep, 22	2	100.00%
30 Jun, 22	1	-66.67%
31 Mar, 22	3	50.00%
31 Dec, 21	2	-
30 Sep, 21	-	-

- institutional shareholders have reduced their position in EFTR stock as of 30 Jun 24 compared to 2 in the previous quarter (a -100.00% decrease).

All Institutional Ownership Trend Data

Date	Holdings	Change %	Shares Outstanding	Change %	Ownership %	Change %	Increased Positions	Change %	Reduced Positions	Change %
30 Jun, 24	2	-	120,081	-	2.94%	9.76%	-	-	-	-100.00%
31 Mar, 24	2	-92.00%	120,081	-98.97%	5.49%	958.91%	-	-100.00%	2	-50.00%
31 Dec, 23	25	-13.79%	11,685,202	-50.21%	0.76%	0.03%	10	-16.67%	4	33.33%
30 Sep, 23	29	-17.14%	23,468,478	-3.95%	49.07%	1.45%	12	-14.29%	3	-
30 Jun, 23	35	29.63%	24,433,689	3.52%	58.17%	1.84%	14	55.56%	3	-50.00%
31 Mar, 23	27	-12.90%	23,602,595	-2.96%	56.20%	1.61%	9	-18.18%	6	100.00%
31 Dec, 22	31	14.81%	24,322,398	1.54%	59.06%	1.74%	11	-	3	50.00%
30 Sep, 22	27	17.39%	23,953,044	-0.65%	58.18%	1.69%	11	-15.38%	2	100.00%
30 Jun, 22	23	27.78%	24,110,440	7.29%	58.64%	1.94%	13	62.50%	1	-66.67%
31 Mar, 22	18	5.88%	22,473,205	5.01%	55.02%	1.96%	8	-33.33%	3	50.00%
31 Dec, 21	17	41.67%	21,402,003	59.39%	53.00%	4.79%	12	-	2	-
30 Sep, 21	12	-	13,427,860	-	33.25%	-	12	-	-	-

eFFECTOR Therapeutics Insider Shareholders Trades

Open Market Insider Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source
Nov 29, 2023	SR ONE CAPITAL MANAGEMENT, LLC	10 percent owner	-	S-Sale	Sell	430,578	$0.61	$261.15K	4,391,536
Nov 29, 2023	SR ONE CAPITAL MANAGEMENT, LLC	10 percent owner	-	S-Sale	Sell	178,585	$0.61	$108.31K	1,821,415

Open Market Insider Buys

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source

Insider Sells

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source
Nov 29, 2023	SR ONE CAPITAL MANAGEMENT, LLC	10 percent owner	-	S-Sale	Sell	430,578	$0.61	$261.15K	4,391,536
Nov 29, 2023	SR ONE CAPITAL MANAGEMENT, LLC	10 percent owner	-	S-Sale	Sell	178,585	$0.61	$108.31K	1,821,415

All Insider Owners Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Jun 13, 2024	Loewy Caroline M	director	-	A-Award	Buy	800	$1.38	$1.10K	800
Jun 13, 2024	Klencke Barbara	director	-	A-Award	Buy	800	$1.38	$1.10K	800
Jun 13, 2024	Ehrlich Christopher B	director	-	A-Award	Buy	800	$1.38	$1.10K	800
Jun 13, 2024	Harrington-Smith Kristen	director	-	A-Award	Buy	800	$1.38	$1.10K	800
Jun 13, 2024	Gallagher Brian M. Jr.	director	-	A-Award	Buy	800	$1.38	$1.10K	800
Jun 13, 2024	Bhatt Elizabeth	director	-	A-Award	Buy	800	$1.38	$1.10K	800
May 17, 2024	Byrnes Michael	officer	Chief Financial Officer	A-Award	Buy	1,387	$1.68	$2.33K	3,117
May 17, 2024	WORLAND STEPHEN T	director, officer	Chief Executive Officer	A-Award	Buy	1,806	$1.68	$3.04K	12,494
Feb 21, 2024	Loewy Caroline M	director	-	A-Award	Buy	2,000	$11.32	$22.64K	2,000
Feb 21, 2024	Bhatt Elizabeth	director	-	A-Award	Buy	2,000	$11.32	$22.64K	2,000
Feb 21, 2024	Ehrlich Christopher B	director	-	A-Award	Buy	2,000	$11.32	$22.64K	2,000
Feb 21, 2024	Klencke Barbara	director	-	A-Award	Buy	2,000	$11.32	$22.64K	2,000
Feb 21, 2024	Harrington-Smith Kristen	director	-	A-Award	Buy	2,000	$11.32	$22.64K	2,000
Feb 21, 2024	Gallagher Brian M. Jr.	director	-	A-Award	Buy	2,000	$11.32	$22.64K	2,000
Feb 21, 2024	Byrnes Michael	officer	Chief Financial Officer	A-Award	Buy	40,000	$11.32	$452.80K	40,000
Feb 21, 2024	Warner Douglas J	officer	Chief Medical Officer	A-Award	Buy	25,000	$11.32	$283.00K	25,000
Feb 21, 2024	WORLAND STEPHEN T	director, officer	Chief Executive Officer	A-Award	Buy	80,000	$11.32	$905.60K	80,000
Nov 29, 2023	SR ONE CAPITAL MANAGEMENT, LLC	10 percent owner	-	S-Sale	Sell	430,578	$0.61	$261.15K	4,391,536
Nov 29, 2023	SR ONE CAPITAL MANAGEMENT, LLC	10 percent owner	-	S-Sale	Sell	178,585	$0.61	$108.31K	1,821,415
Nov 16, 2023	WORLAND STEPHEN T	director, officer	Chief Executive Officer	A-Award	Buy	5,979	$0.50	$2.97K	267,204

The last insider sell of eFFECTOR Therapeutics's stock was made by SR ONE CAPITAL MANAGEMENT, LLC on Nov 29 2023, selling 430,578 shares at $0.61 per share (valued at $261.15K).

eFFECTOR Therapeutics Insider Ownership Trends

All Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q2 2024	8	-	-
Q1 2024	9	-	-
Q4 2023	2	2	100.00%
Q3 2023	2	2	100.00%
Q2 2023	8	-	-
Q1 2023	10	-	-
Q4 2022	3	-	-
Q3 2022	3	31	9.68%
Q2 2022	19	21	90.48%
Q1 2022	12	-	-
Q4 2021	9	68	13.24%
Q3 2021	38	7	542.86%
Q1 2021	-	11	-
Q3 2020	-	-	-

8 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by eFFECTOR Therapeutics's insiders, as of Q2 2024.

Open Market Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q2 2024	-	-	-
Q1 2024	-	-	-
Q4 2023	-	2	-
Q3 2023	-	-	-
Q2 2023	-	-	-
Q1 2023	-	-	-
Q4 2022	1	-	-
Q3 2022	1	31	3.23%
Q2 2022	3	21	14.29%
Q1 2022	7	-	-
Q4 2021	-	68	-
Q3 2021	-	-	-
Q1 2021	-	-	-
Q3 2020	-	-	-

As of Q2 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of eFFECTOR Therapeutics's stocks.

eFFECTOR Therapeutics Peer Ownership

Ticker	Company
ENSC	Ensysce Biosciences, Inc.
VRPX	Virpax Pharmaceuticals, Inc.
RNXT	RenovoRx, Inc.
JSPR	Jasper Therapeutics, Inc.
INDP	Indaptus Therapeutics, Inc.

EFTR Ownership FAQ

Who Owns eFFECTOR Therapeutics?

eFFECTOR Therapeutics is owned by institutional shareholders (2.94%), insiders (2.91%), and public (94.15%). The largest institutional shareholder of eFFECTOR Therapeutics is PARALLEL ADVISORS, LLC (1.66% of total shares) and the top mutual fund owner is ALPS ETF Trust (0.00% of total shares).

Who are the major institutional shareholders of eFFECTOR Therapeutics?

eFFECTOR Therapeutics's major institutional shareholders are PARALLEL ADVISORS, LLC, and BLACKSTONE INC.. The top five shareholders own together 2.94% of the company's share outstanding.

How many eFFECTOR Therapeutics shareholders are there?

As of Jun 2024, there are 2 institutional shareholders of eFFECTOR Therapeutics.

What percentage of eFFECTOR Therapeutics is owned by PARALLEL ADVISORS, LLC?

PARALLEL ADVISORS, LLC owns 67.74K shares of eFFECTOR Therapeutics, representing 1.66% of the company's total shares outstanding, valued at $19.65K (as of Jun 2024).

What percentage of eFFECTOR Therapeutics is owned by BLACKSTONE INC?

As of Jun 2024, BLACKSTONE INC holds 52.34K shares of eFFECTOR Therapeutics (EFTR), compromising 1.28% of the company, valued at $15.18K.